| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.901 | 0.001 | 0.916 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.705 0.002 DBMET00036 0.916 0.001 DBMET00037 0.907 0.001 DBMET00038 | DBMET00037 | |
| 0.717 | 0.004 | 0.721 | Platelet adhesion inhibitor | 0.701 0.004 DBMET00036 0.721 0.003 DBMET00037 0.711 0.004 DBMET00038 | DBMET00037 | |
| 0.696 | 0.024 | 0.747 | Caspase 9 stimulant | 0.605 0.035 DBMET00036 0.747 0.018 DBMET00037 0.747 0.018 DBMET00038 | DBMET00038 | |
| 0.536 | 0.024 | 0.555 | Antithrombotic | 0.555 0.022 DBMET00036 0.54 0.024 DBMET00037 0.542 0.023 DBMET00038 | DBMET00036 | |
| 0.488 | 0.017 | 0.554 | Free radical scavenger | 0.554 0.011 DBMET00036 0.552 0.012 DBMET00037 0.526 0.014 DBMET00038 | DBMET00036 | |
| 0.472 | 0.025 | 0.533 | 12-Lipoxygenase inhibitor | 0.434 0.031 DBMET00036 0.533 0.018 DBMET00037 0.509 0.02 DBMET00038 | DBMET00037 | |
| 0.475 | 0.038 | 0.492 | Histamine release inhibitor | 0.415 0.068 DBMET00036 0.485 0.034 DBMET00037 0.492 0.032 DBMET00038 | DBMET00038 | |
| 0.477 | 0.048 | 0.553 | Transcription factor NF kappa B inhibitor | 0.52 0.041 DBMET00036 0.553 0.037 DBMET00037 0.534 0.039 DBMET00038 | DBMET00037 | |
| 0.436 | 0.008 | 0.436 | Thrombolytic | 0.407 0.01 DBMET00036 0.432 0.009 DBMET00037 0.436 0.008 DBMET00038 | ||
| 0.462 | 0.044 | 0.474 | Immunosuppressant | 0.474 0.04 DBMET00036 0.462 0.043 DBMET00037 0.458 0.045 DBMET00038 | DBMET00036 | |
| 0.442 | 0.025 | 0.445 | Vasodilator, coronary | 0.405 0.034 DBMET00036 0.445 0.024 DBMET00037 0.44 0.025 DBMET00038 | DBMET00037 | |
| 0.417 | 0.015 | 0.417 | Anticoagulant | 0.384 0.018 DBMET00036 0.402 0.016 DBMET00037 0.399 0.016 DBMET00038 | ||
| 0.413 | 0.012 | 0.441 | Non-steroidal antiinflammatory agent | 0.441 0.01 DBMET00036 0.419 0.011 DBMET00037 0.411 0.012 DBMET00038 | DBMET00036 | |
| 0.417 | 0.032 | 0.494 | Antioxidant | 0.478 0.023 DBMET00036 0.494 0.021 DBMET00037 0.463 0.025 DBMET00038 | DBMET00037 | |
| 0.395 | 0.012 | 0.496 | Melanin inhibitor | 0.44 0.009 DBMET00036 0.496 0.007 DBMET00037 0.478 0.008 DBMET00038 | DBMET00037 | |
| 0.401 | 0.023 | 0.412 | Vasodilator | 0.393 0.024 DBMET00036 0.412 0.021 DBMET00037 0.409 0.021 DBMET00038 | DBMET00037 | |
| 0.395 | 0.023 | 0.411 | Sigma receptor agonist | 0.372 0.026 DBMET00036 0.38 0.025 DBMET00037 0.411 0.02 DBMET00038 | DBMET00038 | |
| 0.402 | 0.047 | 0.525 | Aldehyde oxidase inhibitor | 0.256 0.08 DBMET00036 0.525 0.029 DBMET00037 0.507 0.032 DBMET00038 | DBMET00037 | |
| 0.371 | 0.027 | 0.434 | Transcription factor STAT inhibitor | 0.434 0.013 DBMET00036 0.387 0.022 DBMET00037 0.365 0.029 DBMET00038 | DBMET00036 | |
| 0.442 | 0.098 | 0.503 | Alpha-glucosidase inhibitor | 0.463 0.091 DBMET00036 0.503 0.08 DBMET00037 0.49 0.083 DBMET00038 | DBMET00037 | |
| 0.378 | 0.045 | 0.409 | Apoptosis antagonist | 0.409 0.036 DBMET00036 0.406 0.037 DBMET00037 0.385 0.043 DBMET00038 | DBMET00036 | |
| 0.406 | 0.074 | 0.42 | 5 Hydroxytryptamine release inhibitor | 0.372 0.097 DBMET00036 0.418 0.067 DBMET00037 0.42 0.066 DBMET00038 | DBMET00038 | |
| 0.366 | 0.054 | 0.436 | Caspase 3 stimulant | 0.436 0.033 DBMET00036 0.406 0.043 DBMET00037 0.399 0.045 DBMET00038 | DBMET00036 | |
| 0.359 | 0.05 | 0.371 | Spasmolytic | 0.37 0.047 DBMET00036 0.371 0.047 DBMET00037 0.367 0.048 DBMET00038 | DBMET00037 | |
| 0.415 | 0.107 | 0.461 | Apoptosis agonist | 0.456 0.089 DBMET00036 0.461 0.087 DBMET00037 0.442 0.095 DBMET00038 | DBMET00037 | |
| 0.369 | 0.077 | 0.369 | Calpain 2 inhibitor | 0.337 0.093 DBMET00036 0.324 0.1 DBMET00037 0.324 0.1 DBMET00038 | ||
| 0.36 | 0.069 | 0.36 | Vasodilator, peripheral | 0.306 0.094 DBMET00036 0.33 0.082 DBMET00037 0.35 0.074 DBMET00038 | ||
| 0.294 | 0.012 | 0.294 | Succinate dehydrogenase inhibitor | 0.262 0.019 DBMET00036 0.291 0.012 DBMET00037 0.29 0.012 DBMET00038 | ||
| 0.302 | 0.053 | 0.358 | Transcription factor STAT3 inhibitor | 0.358 0.03 DBMET00036 0.311 0.048 DBMET00037 0.288 0.059 DBMET00038 | DBMET00036 | |
| 0.289 | 0.046 | 0.315 | Cyclic AMP phosphodiesterase inhibitor | 0.206 0.089 DBMET00036 0.295 0.044 DBMET00037 0.315 0.036 DBMET00038 | DBMET00038 | |
| 0.309 | 0.067 | 0.34 | Lipoxygenase inhibitor | 0.324 0.06 DBMET00036 0.332 0.057 DBMET00037 0.34 0.054 DBMET00038 | DBMET00038 | |
| 0.254 | 0.019 | 0.284 | Alkaline phosphatase inhibitor | 0.231 0.024 DBMET00036 0.284 0.014 DBMET00037 0.258 0.018 DBMET00038 | DBMET00037 | |
| 0.252 | 0.018 | 0.355 | Aldehyde dehydrogenase inhibitor | 0.181 0.033 DBMET00036 0.355 0.007 DBMET00037 0.275 0.014 DBMET00038 | DBMET00037 | |
| 0.34 | 0.108 | 0.362 | Antibacterial | 0.362 0.095 DBMET00036 0.358 0.097 DBMET00037 0.344 0.105 DBMET00038 | DBMET00036 | |
| 0.242 | 0.01 | 0.295 | Mediator release inhibitor | 0.247 0.01 DBMET00036 0.295 0.007 DBMET00037 0.238 0.01 DBMET00038 | DBMET00037 | |
| 0.265 | 0.044 | 0.383 | Anesthetic general | 0.383 0.019 DBMET00036 0.254 0.049 DBMET00037 0.242 0.054 DBMET00038 | DBMET00036 | |
| 0.255 | 0.036 | 0.271 | Neurotrophic factor enhancer | 0.237 0.046 DBMET00036 0.236 0.047 DBMET00037 0.271 0.028 DBMET00038 | DBMET00038 | |
| 0.298 | 0.094 | 0.3 | Calcium channel activator | 0.3 0.092 DBMET00036 0.29 0.102 DBMET00037 0.281 0.112 DBMET00038 | DBMET00036 | |
| 0.211 | 0.007 | 0.211 | Chymotrypsin inhibitor | 0.184 0.01 DBMET00036 0.195 0.009 DBMET00037 0.203 0.008 DBMET00038 | ||
| 0.253 | 0.071 | 0.253 | Platelet antagonist | 0.215 0.091 DBMET00036 0.253 0.071 DBMET00037 0.244 0.075 DBMET00038 | ||
| 0.189 | 0.009 | 0.261 | Aromatase inhibitor | 0.166 0.011 DBMET00036 0.261 0.006 DBMET00037 0.248 0.007 DBMET00038 | DBMET00037 | |
| 0.235 | 0.056 | 0.272 | Nitric oxide antagonist | 0.251 0.051 DBMET00036 0.272 0.046 DBMET00037 0.261 0.049 DBMET00038 | DBMET00037 | |
| 0.202 | 0.033 | 0.295 | Monophenol monooxygenase inhibitor | 0.26 0.023 DBMET00036 0.295 0.018 DBMET00037 0.265 0.022 DBMET00038 | DBMET00037 | |
| 0.184 | 0.015 | 0.19 | Calcium antagonist | 0.19 0.015 DBMET00036 0.148 0.023 DBMET00037 0.144 0.025 DBMET00038 | DBMET00036 | |
| 0.313 | 0.146 | 0.339 | Calcium channel L-type activator | 0.313 0.146 DBMET00036 0.339 0.126 DBMET00037 0.309 0.15 DBMET00038 | DBMET00037 | |
| 0.278 | 0.113 | 0.278 | Prostaglandin dehydrogenase inhibitor | 0.212 0.149 DBMET00036 0.277 0.113 DBMET00037 0.261 0.121 DBMET00038 | ||
| 0.205 | 0.04 | 0.241 | Lipid peroxidase inhibitor | 0.235 0.03 DBMET00036 0.241 0.029 DBMET00037 0.229 0.032 DBMET00038 | DBMET00037 | |
| 0.209 | 0.056 | 0.219 | Dual specificity phosphatase 3 inhibitor | 0.18 0.073 DBMET00036 0.219 0.052 DBMET00037 0.201 0.06 DBMET00038 | DBMET00037 | |
| 0.17 | 0.022 | 0.212 | Carbonic anhydrase III inhibitor | 0.139 0.033 DBMET00036 0.212 0.014 DBMET00037 0.206 0.015 DBMET00038 | DBMET00037 | |
| 0.3 | 0.154 | 0.3 | Transcription factor inhibitor | 0.248 0.188 DBMET00036 0.268 0.175 DBMET00037 0.274 0.17 DBMET00038 | ||
| 0.196 | 0.057 | 0.199 | Dual specificity phosphatase inhibitor | 0.171 0.074 DBMET00036 0.199 0.055 DBMET00037 0.188 0.062 DBMET00038 | DBMET00037 | |
| 0.156 | 0.018 | 0.158 | Electron transport complex I inhibitor | 0.156 0.018 DBMET00036 0.158 0.017 DBMET00037 0.155 0.018 DBMET00038 | DBMET00037 | |
| 0.225 | 0.093 | 0.242 | Superoxide dismutase inhibitor | 0.214 0.103 DBMET00036 0.242 0.08 DBMET00037 0.235 0.085 DBMET00038 | DBMET00037 | |
| 0.198 | 0.066 | 0.226 | Hepatoprotectant | 0.215 0.057 DBMET00036 0.226 0.052 DBMET00037 0.213 0.058 DBMET00038 | DBMET00037 | |
| 0.176 | 0.049 | 0.218 | MAO inhibitor | 0.178 0.048 DBMET00036 0.218 0.036 DBMET00037 0.203 0.04 DBMET00038 | DBMET00037 | |
| 0.294 | 0.169 | 0.294 | DNA polymerase beta inhibitor | 0.224 0.208 DBMET00036 0.275 0.178 DBMET00037 0.288 0.172 DBMET00038 | ||
| 0.145 | 0.024 | 0.172 | DOPA decarboxylase inhibitor | 0.121 0.043 DBMET00036 0.166 0.014 DBMET00037 0.172 0.013 DBMET00038 | DBMET00038 | |
| 0.183 | 0.065 | 0.184 | Mcl-1 antagonist | 0.161 0.08 DBMET00036 0.178 0.068 DBMET00037 0.184 0.065 DBMET00038 | DBMET00038 | |
| 0.144 | 0.028 | 0.17 | Beta glucuronidase inhibitor | 0.128 0.039 DBMET00036 0.17 0.018 DBMET00037 0.157 0.022 DBMET00038 | DBMET00037 | |
| 0.231 | 0.118 | 0.251 | Hypoxia-inducible factor 1 alpha inhibitor | 0.223 0.126 DBMET00036 0.25 0.1 DBMET00037 0.251 0.099 DBMET00038 | DBMET00038 | |
| 0.125 | 0.018 | 0.135 | HIV-1 integrase (3'-Processing) inhibitor | 0.131 0.017 DBMET00036 0.135 0.016 DBMET00037 0.133 0.016 DBMET00038 | DBMET00037 | |
| 0.164 | 0.059 | 0.191 | Protein kinase stimulant | 0.154 0.065 DBMET00036 0.191 0.045 DBMET00037 0.191 0.045 DBMET00038 | DBMET00038 | |
| 0.124 | 0.02 | 0.143 | Glutathione S-transferase inhibitor | 0.143 0.014 DBMET00036 0.137 0.015 DBMET00037 0.116 0.025 DBMET00038 | DBMET00036 | |
| 0.127 | 0.026 | 0.127 | Porphobilinogen synthase inhibitor | 0.124 0.027 DBMET00036 0.111 0.031 DBMET00037 0.092 0.04 DBMET00038 | ||
| 0.15 | 0.052 | 0.163 | Farnesoid X receptor antagonist | 0.149 0.054 DBMET00036 0.163 0.039 DBMET00037 0.163 0.039 DBMET00038 | DBMET00038 | |
| 0.186 | 0.089 | 0.2 | Pyruvate kinase inhibitor | 0.154 0.112 DBMET00036 0.2 0.081 DBMET00037 0.2 0.081 DBMET00038 | DBMET00038 | |
| 0.137 | 0.041 | 0.163 | Chelator | 0.13 0.045 DBMET00036 0.163 0.032 DBMET00037 0.141 0.039 DBMET00038 | DBMET00037 | |
| 0.137 | 0.043 | 0.15 | 5-Lipoxygenase inhibitor | 0.134 0.044 DBMET00036 0.148 0.038 DBMET00037 0.15 0.038 DBMET00038 | DBMET00038 | |
| 0.12 | 0.027 | 0.12 | CYP2A6 inhibitor | 0.074 0.054 DBMET00036 0.088 0.043 DBMET00037 0.081 0.047 DBMET00038 | ||
| 0.13 | 0.042 | 0.161 | Butyrylcholinesterase inhibitor | 0.138 0.039 DBMET00036 0.161 0.03 DBMET00037 0.139 0.039 DBMET00038 | DBMET00037 | |
| 0.107 | 0.02 | 0.116 | HIV-1 integrase (Strand Transfer) inhibitor | 0.115 0.018 DBMET00036 0.116 0.018 DBMET00037 0.111 0.019 DBMET00038 | DBMET00037 | |
| 0.267 | 0.181 | 0.267 | DNA directed DNA polymerase inhibitor | 0.248 0.193 DBMET00037 0.263 0.184 DBMET00038 | ||
| 0.096 | 0.011 | 0.096 | Factor IXa inhibitor | 0.088 0.013 DBMET00036 0.089 0.013 DBMET00037 0.09 0.013 DBMET00038 | ||
| 0.179 | 0.094 | 0.188 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.169 0.109 DBMET00036 0.187 0.085 DBMET00037 0.188 0.083 DBMET00038 | DBMET00038 | |
| 0.124 | 0.04 | 0.124 | UDP-glucose 4-epimerase inhibitor | 0.118 0.045 DBMET00036 0.112 0.049 DBMET00037 0.108 0.052 DBMET00038 | ||
| 0.116 | 0.033 | 0.123 | Thioredoxin inhibitor | 0.113 0.036 DBMET00036 0.123 0.029 DBMET00037 0.118 0.032 DBMET00038 | DBMET00037 | |
| 0.23 | 0.148 | 0.23 | Thioredoxin glutathione reductase inhibitor | 0.194 0.177 DBMET00037 0.212 0.162 DBMET00038 | ||
| 0.139 | 0.062 | 0.179 | Acetylcholinesterase inhibitor | 0.147 0.057 DBMET00036 0.179 0.04 DBMET00037 0.153 0.054 DBMET00038 | DBMET00037 | |
| 0.108 | 0.034 | 0.144 | Carbonic anhydrase XIII inhibitor | 0.085 0.047 DBMET00036 0.144 0.023 DBMET00037 0.136 0.025 DBMET00038 | DBMET00037 | |
| 0.1 | 0.029 | 0.1 | Thioredoxin reductase inhibitor | 0.096 0.033 DBMET00036 0.095 0.034 DBMET00037 0.098 0.03 DBMET00038 | ||
| 0.19 | 0.123 | 0.19 | Calpain inhibitor | 0.164 0.158 DBMET00036 0.175 0.141 DBMET00037 0.172 0.145 DBMET00038 | ||
| 0.109 | 0.044 | 0.138 | Alcohol dehydrogenase inhibitor | 0.095 0.058 DBMET00036 0.138 0.025 DBMET00037 0.126 0.031 DBMET00038 | DBMET00037 | |
| 0.12 | 0.059 | 0.126 | TRPA1 agonist | 0.124 0.054 DBMET00037 0.126 0.051 DBMET00038 | DBMET00038 | |
| 0.133 | 0.072 | 0.135 | Interleukin 1 antagonist | 0.135 0.07 DBMET00037 0.126 0.081 DBMET00038 | DBMET00037 | |
| 0.114 | 0.053 | 0.144 | MAO B inhibitor | 0.093 0.063 DBMET00036 0.144 0.039 DBMET00037 0.134 0.044 DBMET00038 | DBMET00037 | |
| 0.13 | 0.071 | 0.16 | Interleukin 4 antagonist | 0.126 0.077 DBMET00036 0.16 0.042 DBMET00037 0.149 0.051 DBMET00038 | DBMET00037 | |
| 0.067 | 0.009 | 0.067 | HIV-1 protease inhibitor | 0.063 0.01 DBMET00036 0.066 0.009 DBMET00037 0.064 0.009 DBMET00038 | ||
| 0.113 | 0.056 | 0.153 | MAO A inhibitor | 0.124 0.051 DBMET00036 0.153 0.04 DBMET00037 0.14 0.044 DBMET00038 | DBMET00037 | |
| 0.063 | 0.006 | 0.068 | Catechol O-methyltransferase inhibitor | 0.063 0.006 DBMET00036 0.068 0.005 DBMET00037 0.067 0.006 DBMET00038 | DBMET00037 | |
| 0.088 | 0.037 | 0.088 | Phosphofructokinase-1 inhibitor | 0.08 0.041 DBMET00036 0.08 0.041 DBMET00037 0.08 0.041 DBMET00038 | ||
| 0.123 | 0.075 | 0.143 | Papain-like protease (SARS coronavirus) inhibitor | 0.143 0.041 DBMET00037 0.13 0.061 DBMET00038 | DBMET00037 | |
| 0.055 | 0.007 | 0.055 | Glutamate (mGluR8) antagonist | 0.048 0.009 DBMET00036 0.049 0.009 DBMET00037 0.051 0.008 DBMET00038 | ||
| 0.093 | 0.044 | 0.112 | Topoisomerase II alpha inhibitor | 0.071 0.061 DBMET00036 0.112 0.033 DBMET00037 0.11 0.034 DBMET00038 | DBMET00037 | |
| 0.089 | 0.041 | 0.089 | T cell inhibitor | 0.081 0.06 DBMET00036 0.085 0.049 DBMET00037 0.085 0.048 DBMET00038 | ||
| 0.106 | 0.059 | 0.106 | Adenylate kinase inhibitor | 0.097 0.073 DBMET00036 0.094 0.079 DBMET00037 0.091 0.086 DBMET00038 | ||
| 0.099 | 0.052 | 0.105 | Bile acid receptor antagonist | 0.099 0.051 DBMET00036 0.103 0.042 DBMET00037 0.105 0.04 DBMET00038 | DBMET00038 | |
| 0.127 | 0.082 | 0.127 | Cytokine production inhibitor | 0.109 0.101 DBMET00036 0.122 0.087 DBMET00037 0.118 0.092 DBMET00038 | ||
| 0.099 | 0.055 | 0.099 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.095 0.059 DBMET00036 0.087 0.07 DBMET00037 | ||
| 0.114 | 0.071 | 0.114 | Anesthetic local | 0.093 0.09 DBMET00038 | ||
| 0.135 | 0.093 | 0.147 | Phospholipase A2 inhibitor | 0.129 0.103 DBMET00036 0.147 0.078 DBMET00037 0.144 0.081 DBMET00038 | DBMET00037 | |
| 0.111 | 0.07 | 0.111 | Photosensitizer | 0.102 0.085 DBMET00036 0.109 0.073 DBMET00037 0.101 0.086 DBMET00038 | ||
| 0.147 | 0.107 | 0.147 | 3C-like protease (Human coronavirus) inhibitor | 0.14 0.119 DBMET00037 0.136 0.127 DBMET00038 | ||
| 0.149 | 0.109 | 0.22 | Amyloid beta aggregation inhibitor | 0.183 0.087 DBMET00036 0.22 0.068 DBMET00037 0.192 0.082 DBMET00038 | DBMET00037 | |
| 0.101 | 0.065 | 0.101 | Protease inhibitor | 0.091 0.073 DBMET00036 0.096 0.069 DBMET00037 0.095 0.069 DBMET00038 | ||
| 0.224 | 0.188 | 0.257 | 15-Lipoxygenase inhibitor | 0.244 0.169 DBMET00036 0.257 0.159 DBMET00037 0.256 0.16 DBMET00038 | DBMET00037 | |
| 0.083 | 0.048 | 0.116 | Macrophage migration inhibitory factor inhibitor | 0.116 0.027 DBMET00037 0.113 0.028 DBMET00038 | DBMET00037 | |
| 0.068 | 0.033 | 0.083 | Androgen agonist | 0.073 0.028 DBMET00037 0.083 0.023 DBMET00038 | DBMET00038 | |
| 0.09 | 0.055 | 0.107 | Androgen antagonist | 0.09 0.054 DBMET00036 0.104 0.044 DBMET00037 0.107 0.042 DBMET00038 | DBMET00038 | |
| 0.092 | 0.057 | 0.092 | Triose-phosphate isomerase inhibitor | 0.091 0.059 DBMET00036 0.085 0.067 DBMET00037 0.083 0.07 DBMET00038 | ||
| 0.18 | 0.146 | 0.18 | Streptokinase A inhibitor | 0.176 0.15 DBMET00037 0.166 0.158 DBMET00038 | ||
| 0.061 | 0.029 | 0.061 | Acetyl-CoA transferase inhibitor | 0.051 0.041 DBMET00036 0.051 0.039 DBMET00037 0.053 0.037 DBMET00038 | ||
| 0.091 | 0.064 | 0.123 | Breast cancer-resistant protein inhibitor | 0.123 0.038 DBMET00036 0.113 0.044 DBMET00037 0.109 0.047 DBMET00038 | DBMET00036 | |
| 0.082 | 0.055 | 0.1 | Carbonic anhydrase VI inhibitor | 0.1 0.039 DBMET00037 0.094 0.044 DBMET00038 | DBMET00037 | |
| 0.148 | 0.12 | 0.166 | P-glycoprotein inhibitor | 0.157 0.107 DBMET00036 0.166 0.094 DBMET00037 0.156 0.107 DBMET00038 | DBMET00037 | |
| 0.039 | 0.012 | 0.04 | Cyclophilin A inhibitor | 0.038 0.013 DBMET00036 0.04 0.011 DBMET00037 0.038 0.013 DBMET00038 | DBMET00037 | |
| 0.063 | 0.038 | 0.065 | Heme oxygenase stimulant | 0.063 0.038 DBMET00036 0.062 0.042 DBMET00037 0.065 0.035 DBMET00038 | DBMET00038 | |
| 0.133 | 0.11 | 0.15 | Arachidonic acid antagonist | 0.15 0.089 DBMET00038 | DBMET00038 | |
| 0.072 | 0.049 | 0.128 | Histidine decarboxylase inhibitor | 0.128 0.024 DBMET00037 0.095 0.034 DBMET00038 | DBMET00037 | |
| 0.058 | 0.036 | 0.058 | Acetyl-CoA transferase 2 inhibitor | 0.055 0.042 DBMET00037 0.055 0.043 DBMET00038 | ||
| 0.131 | 0.11 | 0.151 | Interferon gamma antagonist | 0.138 0.096 DBMET00037 0.151 0.076 DBMET00038 | DBMET00038 | |
| 0.073 | 0.052 | 0.073 | CDC25A inhibitor | 0.069 0.059 DBMET00036 0.073 0.052 DBMET00037 0.068 0.06 DBMET00038 | ||
| 0.058 | 0.043 | 0.058 | Cathepsin E inhibitor | 0.055 0.049 DBMET00036 0.055 0.049 DBMET00037 0.057 0.046 DBMET00038 | ||
| 0.05 | 0.036 | 0.051 | CD45 antagonist | 0.051 0.033 DBMET00037 0.048 0.04 DBMET00038 | DBMET00037 | |
| 0.092 | 0.079 | 0.107 | Carbonic anhydrase XV inhibitor | 0.107 0.059 DBMET00037 0.1 0.067 DBMET00038 | DBMET00037 | |
| 0.062 | 0.049 | 0.07 | Neuraminidase (influenza) inhibitor | 0.064 0.045 DBMET00036 0.07 0.035 DBMET00037 0.065 0.043 DBMET00038 | DBMET00037 | |
| 0.182 | 0.171 | 0.198 | Tyrosine 3 hydroxylase inhibitor | 0.187 0.16 DBMET00036 0.198 0.139 DBMET00037 0.183 0.17 DBMET00038 | DBMET00037 | |
| 0.186 | 0.174 | 0.186 | Thyroid hormone antagonist | 0.18 0.179 DBMET00038 | ||
| 0.086 | 0.076 | 0.1 | Aminopeptidase B inhibitor | 0.1 0.065 DBMET00036 | DBMET00036 | |
| 0.102 | 0.092 | 0.102 | Interleukin 8 antagonist | 0.101 0.094 DBMET00036 | ||
| 0.091 | 0.081 | 0.122 | Estrogen receptor beta antagonist | 0.122 0.03 DBMET00037 0.118 0.034 DBMET00038 | DBMET00037 | |
| 0.065 | 0.056 | 0.068 | HIV-1 integrase inhibitor | 0.064 0.058 DBMET00036 0.068 0.052 DBMET00037 0.065 0.055 DBMET00038 | DBMET00037 | |
| 0.045 | 0.039 | 0.048 | Plasminogen activator inhibitor antagonist | 0.048 0.035 DBMET00038 | DBMET00038 | |
| 0.094 | 0.092 | 0.119 | Topoisomerase II inhibitor | 0.117 0.07 DBMET00037 0.119 0.068 DBMET00038 | DBMET00038 | |
| 0.1 | 0.099 | 0.132 | Estrogen antagonist | 0.132 0.035 DBMET00037 0.129 0.04 DBMET00038 | DBMET00037 | |
| 0.086 | 0.085 | 0.102 | Anabolic | 0.092 0.074 DBMET00037 0.102 0.059 DBMET00038 | DBMET00038 | |
| 0.04 | 0.04 | 0.055 | Carbonic anhydrase VII inhibitor | 0.045 0.033 DBMET00036 0.055 0.023 DBMET00037 0.049 0.029 DBMET00038 | DBMET00037 | |
| 0.117 | 0.118 | 0.132 | Protein-tyrosine phosphatase inhibitor | 0.132 0.099 DBMET00037 0.124 0.108 DBMET00038 | DBMET00037 | |
| 0.164 | 0.168 | 0.194 | Nitric-oxide synthase stimulant | 0.171 0.151 DBMET00036 0.194 0.099 DBMET00037 0.189 0.108 DBMET00038 | DBMET00037 | |
| 0.088 | 0.092 | 0.139 | Cystathionine beta-synthase inhibitor | 0.096 0.082 DBMET00036 0.139 0.046 DBMET00037 0.113 0.064 DBMET00038 | DBMET00037 | |
| 0.12 | 0.127 | 0.125 | Heat shock protein 90 alpha antagonist | 0.125 0.119 DBMET00037 | DBMET00037 | |
| 0.082 | 0.089 | 0.114 | Xanthine oxidase inhibitor | 0.099 0.06 DBMET00036 0.114 0.05 DBMET00037 0.097 0.063 DBMET00038 | DBMET00037 | |
| 0.075 | 0.085 | 0.081 | D-Ala-D-Ala ligase inhibitor | 0.081 0.064 DBMET00037 0.08 0.068 DBMET00038 | DBMET00037 | |
| 0.057 | 0.069 | 0.063 | Transcription factor RelA inhibitor | 0.063 0.046 DBMET00037 0.06 0.056 DBMET00038 | DBMET00037 | |
| 0.059 | 0.072 | 0.064 | Calcium channel L-type blocker | 0.064 0.062 DBMET00036 | DBMET00036 | |
| 0.098 | 0.114 | 0.107 | Transcription factor STAT6 inhibitor | 0.107 0.087 DBMET00036 0.103 0.098 DBMET00037 | DBMET00036 | |
| 0.132 | 0.149 | 0.138 | Phospholipase C inhibitor | 0.138 0.134 DBMET00037 | DBMET00037 | |
| 0.25 | 0.267 | 0.297 | Antiinflammatory | 0.297 0.218 DBMET00037 0.273 0.242 DBMET00038 | DBMET00037 | |
| 0.076 | 0.095 | 0.121 | Creatine kinase inhibitor | 0.084 0.081 DBMET00036 0.121 0.04 DBMET00037 0.097 0.063 DBMET00038 | DBMET00037 | |
| 0.138 | 0.165 | 0.162 | Immunostimulant | 0.162 0.145 DBMET00036 0.162 0.145 DBMET00037 | DBMET00037 | |
| 0.064 | 0.093 | 0.08 | NMDA receptor antagonist | 0.08 0.066 DBMET00037 | DBMET00037 | |
| 0.04 | 0.072 | 0.055 | Neuraminidase inhibitor | 0.055 0.051 DBMET00037 | DBMET00037 | |
| 0.176 | 0.208 | 0.19 | 5 Hydroxytryptamine uptake stimulant | 0.19 0.173 DBMET00037 | DBMET00037 | |
| 0.049 | 0.082 | 0.061 | Carbonic anhydrase VA inhibitor | 0.061 0.058 DBMET00037 | DBMET00037 | |
| 0.032 | 0.067 | 0.047 | Aldose reductase inhibitor | 0.047 0.042 DBMET00037 | DBMET00037 | |
| 0.128 | 0.163 | 0.145 | Platelet aggregation inhibitor | 0.145 0.134 DBMET00038 | DBMET00038 | |
| 0.065 | 0.107 | 0.085 | HIV-1 integrase (Overall Integration) inhibitor | 0.085 0.07 DBMET00036 | DBMET00036 | |
| 0.021 | 0.074 | 0.054 | Estrogen agonist | 0.054 0.033 DBMET00037 0.049 0.036 DBMET00038 | DBMET00037 | |
| 0.093 | 0.151 | 0.122 | Cholinergic | 0.122 0.105 DBMET00037 | DBMET00037 | |
| 0.06 | 0.118 | 0.088 | Urease inhibitor | 0.088 0.081 DBMET00037 | DBMET00037 | |
| 0.06 | 0.119 | 0.086 | Topoisomerase I inhibitor | 0.086 0.084 DBMET00038 | DBMET00038 | |
| 0.137 | 0.196 | 0.167 | DNA damaging | 0.167 0.149 DBMET00036 | DBMET00036 | |
| 0.109 | 0.173 | 0.139 | Interleukin antagonist | 0.139 0.126 DBMET00037 | DBMET00037 | |
| 0.073 | 0.138 | 0.145 | Toll-Like receptor 4 antagonist | 0.145 0.024 DBMET00036 | DBMET00036 | |
| 0.08 | 0.169 | 0.126 | Peroxidase inhibitor | 0.126 0.094 DBMET00037 | DBMET00037 | |
| 0.065 | 0.167 | 0.093 | Multidrug resistance-associated protein 1 inhibitor | 0.093 0.091 DBMET00037 | DBMET00037 | |
| 0.153 | 0.263 | 0.209 | Sodium/bile acid cotransporter inhibitor | 0.209 0.176 DBMET00037 | DBMET00037 | |
| 0.009 | 0.331 | 0.085 | Opioid delta receptor antagonist | 0.085 0.035 DBMET00036 | DBMET00036 | |
| 0.009 | 0.359 | 0.08 | Opioid mu receptor antagonist | 0.08 0.04 DBMET00036 | DBMET00036 | |
| 0.028 | 0.381 | 0.144 | Opioid kappa receptor antagonist | 0.144 0.018 DBMET00036 | DBMET00036 | |
| 0.023 | 0.386 | 0.108 | Opioid antagonist | 0.108 0.043 DBMET00036 | DBMET00036 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |